Description

SUSTEN 200/100 MG

Indications

SUSTEN 200/100 MG is primarily indicated for hormone replacement therapy in women experiencing symptoms of menopause, such as hot flashes, night sweats, and vaginal dryness. It is also used in the treatment of conditions related to progesterone deficiency, including irregular menstrual cycles and certain types of abnormal uterine bleeding. Additionally, SUSTEN may be prescribed to support early pregnancy in women with a history of recurrent miscarriages or infertility due to luteal phase defects.

Mechanism of Action

SUSTEN contains micronized progesterone, which mimics the natural hormone progesterone produced by the ovaries. The primary mechanism of action involves the regulation of the menstrual cycle and the preparation of the endometrium (the lining of the uterus) for potential implantation of a fertilized egg. By promoting a favorable environment for implantation, SUSTEN helps to maintain early pregnancy. Furthermore, it counteracts the effects of estrogen on the endometrium, thereby reducing the risk of hyperplasia and endometrial cancer in women undergoing estrogen therapy.

Pharmacological Properties

The pharmacokinetics of SUSTEN demonstrate that after oral administration, micronized progesterone is rapidly absorbed, with peak plasma concentrations typically occurring within 2 to 4 hours. The bioavailability of micronized progesterone is significantly higher than that of synthetic progestins, allowing for effective dosing at lower quantities. SUSTEN is metabolized primarily in the liver, with metabolites excreted in urine. The elimination half-life is approximately 5 to 20 hours, depending on individual patient factors.

Contraindications

SUSTEN is contraindicated in individuals with known hypersensitivity to progesterone or any of the excipients in the formulation. It should not be used in patients with a history of thromboembolic disorders, such as deep vein thrombosis or pulmonary embolism, as well as those with active liver disease, undiagnosed vaginal bleeding, or breast cancer. Additionally, SUSTEN is not recommended during pregnancy unless specifically indicated for certain conditions, as its effects on fetal development are not fully understood.

Side Effects

Common side effects associated with SUSTEN include fatigue, dizziness, headache, and gastrointestinal disturbances such as nausea and bloating. Some patients may experience mood changes, breast tenderness, or changes in menstrual flow. Serious adverse effects, although rare, may include thromboembolic events, liver dysfunction, and allergic reactions. Patients should be advised to report any unusual symptoms or side effects to their healthcare provider promptly.

Dosage and Administration

The recommended dosage of SUSTEN varies based on the specific indication and the patient’s individual response. For hormone replacement therapy, the typical starting dose is 200 mg taken orally once daily at bedtime for 12 days in a 28-day cycle. For the management of luteal phase defects or support in early pregnancy, a dosage of 100 mg to 200 mg may be administered as directed by a healthcare professional. It is important for patients to follow their healthcare provider’s instructions regarding dosage and duration of therapy to ensure optimal outcomes.

Interactions

SUSTEN may interact with various medications, potentially altering its efficacy or increasing the risk of side effects. Concomitant use of other hormonal therapies, such as estrogen, may enhance the effects of SUSTEN. Additionally, certain medications that induce liver enzymes, such as rifampicin and some anticonvulsants, may decrease the plasma levels of progesterone. Patients should inform their healthcare provider of all medications, supplements, and herbal products they are taking to avoid potential interactions.

Precautions

Patients should use SUSTEN with caution if they have a history of cardiovascular disease, hypertension, diabetes, or epilepsy. Regular monitoring of blood pressure and glucose levels may be necessary during treatment. Women with a history of depression or mood disorders should be closely observed, as hormonal therapies can sometimes exacerbate these conditions. It is also essential to assess the risk of thromboembolic events in patients with additional risk factors, such as obesity or prolonged immobility.

Clinical Studies

Clinical studies have demonstrated the efficacy of SUSTEN in managing menopausal symptoms and supporting early pregnancy. In a randomized controlled trial, women receiving SUSTEN reported a significant reduction in the frequency and severity of hot flashes compared to placebo. Another study highlighted the positive effects of SUSTEN on endometrial health, showing a reduced incidence of hyperplasia in women undergoing estrogen therapy. These findings support the use of SUSTEN as a safe and effective option for hormone replacement and reproductive health management.

Conclusion

SUSTEN 200/100 MG is a valuable therapeutic option for women experiencing menopausal symptoms and those requiring progesterone support in early pregnancy. Its micronized formulation enhances absorption and effectiveness, making it a preferred choice for hormone replacement therapy. While generally well-tolerated, it is essential for patients to be aware of potential side effects and contraindications. Regular follow-up with healthcare providers is crucial to ensure safe and effective use of this medication.